Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Bifunctional epoxide hydrolase 2 | ||
Ligand | BDBM50194496 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_444681 (CHEMBL894930) | ||
IC50 | 220±n/a nM | ||
Citation | Hwang, SH; Tsai, HJ; Liu, JY; Morisseau, C; Hammock, BD Orally bioavailable potent soluble epoxide hydrolase inhibitors. J Med Chem50:3825-40 (2007) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Bifunctional epoxide hydrolase 2 | |||
Name: | Bifunctional epoxide hydrolase 2 | ||
Synonyms: | Cytosolic epoxide hydrolase 2 | EBifunctional epoxide hydrolase 2 | EPHX2 | Epoxide hydratase | HYES_HUMAN | Lipid-phosphate phosphatase | Soluble epoxide hydrolase (sEH) | epoxide hydrolase 2, cytoplasmic | ||
Type: | Enzyme | ||
Mol. Mass.: | 62613.07 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P34913 | ||
Residue: | 555 | ||
Sequence: |
| ||
BDBM50194496 | |||
n/a | |||
Name | BDBM50194496 | ||
Synonyms: | 4-{3-[4-(4-fluoro-phenoxy)-cyclohexyl]-ureido}-benzoic acid | CHEMBL222160 | cis-4-(3-(4-(4-fluorophenoxy)cyclohexyl)ureido)benzoic acid | ||
Type | Small organic molecule | ||
Emp. Form. | C20H21FN2O4 | ||
Mol. Mass. | 372.3901 | ||
SMILES | OC(=O)c1ccc(NC(=O)N[C@H]2CC[C@H](CC2)Oc2ccc(F)cc2)cc1 |wD:14.17,11.10,(2.04,-5.24,;3.32,-4.45,;3.28,-2.95,;4.64,-5.17,;5.96,-4.36,;7.31,-5.1,;7.35,-6.64,;8.71,-7.38,;10.01,-6.55,;10,-4.91,;11.31,-7.38,;12.61,-6.55,;13.91,-7.37,;15.2,-6.55,;15.2,-4.91,;13.91,-4.08,;12.61,-4.91,;16.51,-4.09,;17.81,-4.91,;17.8,-6.56,;19.1,-7.39,;20.41,-6.57,;21.71,-7.39,;20.4,-4.92,;19.11,-4.1,;6.04,-7.45,;4.69,-6.72,)| | ||
Structure |